{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:18Z","timestamp":1747207338676,"version":"3.40.5"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Thiazolo- and thiadiazolo-[3,2-a][1,3]diazepines and their patented derivatives, tested with\ndiverse CNS pharmacological activities, constitute an important class of compounds for new drug development.\nTherefore, research efforts were continued to design, synthesize, and evaluate compounds\nfor their ultra-short, short-acting hypnotic, anticonvulsant, and neuromuscular blocking activities. The\npresent review provides a summary of the work accomplished by these heterocycles and their biological\nevaluation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557521999201230195733","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T07:53:18Z","timestamp":1609487598000},"page":"1048-1057","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel GABAA Agonist Entities: Pharmacological Investigation and Molecular Modeling Study of Thiazolo- and Thiadiazolo-[3,2-a][1,3]diazepine Analogs"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-9883","authenticated-orcid":true,"given":"Hussein I.","family":"El-Subbagh","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, College of Pharmacy, Mansoura University, Mansoura 35516,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejmech.2003.11.009","volume":"39","author":"Kie\u0107-Kononowicz K.","year":"2004","unstructured":"Kie\u0107-Kononowicz K.; Karolak-Wojciechowska J.; Michalak B.; Pekala E.; Schumacher B.; M\u00fcller C.E.; Imidazo[2,1-b]thiazepines: Synthesis, structure and evaluation of benzodiazepine receptor binding. Eur J Med Chem 2004,39(3),205-218","journal-title":"Eur J Med Chem"},{"key":"ref=2","first-page":"13463","volume":"43","author":"Zhu M.","year":"2019","unstructured":"Zhu M.; Wu X.; Sang L.; Fan F.; Wang L.; Wu X.; Hua R.; Wang Y.; Lib Q.X.; A novel and effective benzo[d]thiazole-based fluorescent probe with dual recognition factors for highly sensitive and selective imaging of cysteine in vitro and in vivo. Sci Total Environ 2019,43,13463-13470","journal-title":"Sci Total Environ"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jlumin.2018.09.005","volume":"205","author":"Wanga Y.","year":"2019","unstructured":"Wanga Y.; Wanga L.; Zhua M.; Xuea J.; Huaa R.; Lib Q.X.; Comparative studies on biophysical interactions between gambogic acid and serum albumin via multispectroscopic approaches and molecular docking. J Lumin 2019,205,210-218","journal-title":"J Lumin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"17735","DOI":"10.1007\/s11356-018-1955-9","volume":"25","author":"Zhu M.","year":"2018","unstructured":"Zhu M.; Wang L.; Zhang H.; Fan S.; Wang Z.; Li Q.X.; Wang Y.; Liu S.; Interactions between tetrahydroisoindoline-1,3-dione derivatives and human serum albumin via multiple spectroscopy techniques. Environ Sci Pollut Res Int 2018,25(18),17735-17748","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ijerph15010116","volume":"15","author":"Zhu M.","year":"2018","unstructured":"Zhu M.; Wang L.; Wang Y.; Zhou J.; Ding J.; Li W.; Xin Y.; Fan S.; Wang Z.; Wang Y.; Biointeractions of herbicide atrazine with human serum albumin: UV-vis, fluorescence and circular dichroism approaches. Int J Env Res Pub He 2018,15(1),116","journal-title":"Int J Env Res Pub He"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ardp.19953280302","volume":"328","author":"Imming P.","year":"1995","unstructured":"Imming P.; Synthesis of the first penicillin derivatives with medium-sized lactam ring and of related thiazolidines. Arch Pharm (Weinheim) 1995,328,207-215","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jhet.5570370540","volume":"37","author":"Ueda T.","year":"2000","unstructured":"Ueda T.; Doi W.; Nagai S.I.; Sakakibara J.; Synthesis of [1,2,5]selena(or thia)diazolo[3,4-e]-[1,4]diazepines, [1,2,5]selena(or thia)diazolo[3,4-e][1,4]oxazepines and [1,2,5]selena(or thia) diazolo[3,4-c][1,2,6]thiadiazines. J Heterocycl Chem 2000,37,1269-1272","journal-title":"J Heterocycl Chem"},{"key":"ref=8","author":"Pissiotas G.","year":"1995","unstructured":"Pissiotas G.; Moser H.; Brunner H.; Herbicidal 1H,3H,5H-[1,3,4]thiadiazolo[3,4-a][1,2]di-azepin-1-ones and analogs. PCT Int Appl WO 9500521 A1199501051995","journal-title":"PCT Int Appl WO"},{"key":"ref=9","first-page":"321","author":"Marshall B.E.","year":"1996","unstructured":"Marshall B.E.; Longnecker D.E.;  The Pharmacological Basis of Therapeutics, 9th ed; J G, Hardman; L E, Limbird, Eds; McGraw-Hill: New York, 1996,321-323","journal-title":"The Pharmacological Basis of Therapeutics, 9th ed; J G, Hardman; L E, Limbird, Eds; McGraw-Hill: New York,"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00000542-197510000-00010","volume":"43","author":"Shapiro H.M.","year":"1975","unstructured":"Shapiro H.M.; Intracranial hypertension: Therapeutic and anesthetic considerations. Anesthesiology 1975,43(4),445-471","journal-title":"Anesthesiology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","volume":"328","author":"Shader R.I.","year":"1993","unstructured":"Shader R.I.; Greenblatt D.J.; Use of benzodiazepines in anxiety disorders. N Engl J Med 1993,328(19),1398-1405","journal-title":"N Engl J Med"},{"key":"ref=12","first-page":"723","volume":"17","author":"Saab R.N.","year":"2004","unstructured":"Saab R.N.;  Anesthesia for the premature infantMiddle East J Anaesthesiol, 2004,17(4),723-744","journal-title":"Anesthesia for the premature infantMiddle East J Anaesthesiol,"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2165\/00002512-200320130-00002","volume":"20","author":"Eilers H.","year":"2003","unstructured":"Eilers H.; Niemann C.; Clinically important drug interactions with intravenous anaesthetics in older patients. Drugs Aging 2003,20(13),969-980","journal-title":"Drugs Aging"},{"key":"ref=14","first-page":"315","author":"Hardman J.","year":"2001","unstructured":"Hardman J.; Limbird L.E.; Hardman J.; Limbird L.E.;  Goodman  McGraw-Hill Medical Pub 2001,315-319","journal-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics; McGraw-Hill Medical Pub"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00002018-199818040-00001","volume":"18","author":"Naguib M.","year":"1998","unstructured":"Naguib M.; Magboul M.M.; Samarkandi A.H.; Attia M.; Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Saf 1998,18(4),221-250","journal-title":"Drug Saf"},{"key":"ref=16","first-page":"73","volume":"15","author":"Khan-Ghori S.N.","year":"1999","unstructured":"Khan-Ghori S.N.; Murshid W.R.; Samarkandi A.H.; Al-Salman M.; Salih M.A.;  Use of propofol and sevoflurane in moyamoya disease-case reports and literature reviewMiddle East J Anaesthesiol, 1999,15(1),73-83","journal-title":"Use of propofol and sevoflurane in moyamoya disease-case reports and literature reviewMiddle East J Anaesthesiol,"},{"key":"ref=17","first-page":"503","author":"Rang H.P.","year":"2005","unstructured":"Rang H.P.; Dale M.M.; Ritter J.M.;  General anesthetic agents Pharmacology 2005,503-515","journal-title":"General anesthetic agents Pharmacology"},{"key":"ref=18","first-page":"515","author":"Rang H.P.","year":"2005","unstructured":"Rang H.P.; Dale M.M.; Ritter J.M.;  Anxiolytic and hypnotic drugs Pharmacology 2005,515-527","journal-title":"Anxiolytic and hypnotic drugs Pharmacology"},{"key":"ref=19","first-page":"119","author":"Marshall B.E.","year":"1995","unstructured":"Marshall B.E.; Hanson C.W.; Marshall C.;  Clinical physiology and pathophysiology of the respiratory system A Practice of Anesthesia; Healy, D 1995,119-145","journal-title":"Clinical physiology and pathophysiology of the respiratory system A Practice of Anesthesia; Healy, D"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bmcl.2007.11.011","volume":"18","author":"El-Subbagh H.I.","year":"2008","unstructured":"El-Subbagh H.I.; El-Kashef H.A.; Kadi A.A.; Abdel-Aziz A.A-M.; Hassan G.S.; Tettey J.; Lehmann J.; New ultra-short acting hypnotic: Synthesis, biological evaluation, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carbo-xylate (HIE-124). Bioorg Med Chem Lett 2008,18(1),72-77","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ardp.200700132","volume":"341","author":"Kadi A.A.","year":"2008","unstructured":"Kadi A.A.; El-Kashef H.A.; Abdel-Aziz A.A-M.; Hassan G.S.; Tettey J.; Grant M.H.; Lehmann J.; El-Subbagh H.I.; Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124). Arch Pharm (Weinheim) 2008,341(2),81-89","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=22","author":"Lehmann J.","year":"2004","unstructured":"Lehmann J.; El-Subbagh H.I.; El-Kashef H.A.;  Neue schnell wirkende Anesthetika New ultra-short acting hypnotics German Patent DE 103 20 732 A1 2004","journal-title":"Neue schnell wirkende Anesthetika New ultra-short acting hypnotics German Patent DE 103 20 732 A1"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1556\/JPC.22.2009.3.4","volume":"22","author":"Abourashed E.A.","year":"2009","unstructured":"Abourashed E.A.; Hefnawy M.M.; H.I., El-Subbagh HPTLC analysis of a new ultra-short-acting thiazolodiazepine hypnotic (HIE-124) in spiked human plasma. J Planar Chromatog 2009,22,183-186","journal-title":"J Planar Chromatog"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.aca.2010.05.030","volume":"673","author":"Hefnawy M.","year":"2010","unstructured":"Hefnawy M.; Al-Omar M.; Julkhuf S.; Attia S.; Abourashed E.; El-Subbagh H.; Novel, selective sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the determination of the new ultra-short acting hypnotic \u201cHIE-124\u201d in mice serum. Anal Chim Acta 2010,673(2),194-199","journal-title":"Anal Chim Acta"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1039\/C0AN00381F","volume":"136","author":"Kadi A.","year":"2011","unstructured":"Kadi A.; Hefnawy M.; Al-Majed A.; Alonezi S.; Asiri Y.; Attia S.; Abourashed E.; El-Subbagh H.; Liquid chromatographic high-throughput analysis of the new ultra-short acting hypnotic \u2018HIE-124\u2019 and its metabolite in mice serum using a monolithic silica column. Analyst (Lond) 2011,136(3),591-597","journal-title":"Analyst (Lond)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bmcl.2015.11.097","volume":"26","author":"Al-Rashood S.T.A.","year":"2016","unstructured":"Al-Rashood S.T.A.; Hassan G.S.; El-Messery S.M.; El-Taher K.E.H.; Hefnawy M.M.; Al-Omar M.A.; El-Subbagh H.I.; Synthesis, biological evaluation and molecular modeling study of some new thiazolodiazepine analogs as CNS active agents. Bioorg Med Chem Lett 2016,26(2),445-453","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","author":"Al-Rashood S.T.A.","year":"2016","unstructured":"Al-Rashood S.T.A.; El-Subbagh H.I.; Hassan G.S.; El-Taher K.E.H.; Al-Omar M.A.;  Thiazolo[3,2-a][1,3]diazepine derivatives\nand pharmaceutical compositions containing the same as novel anticonvulsant\nagents and method for their preparation Europ Pat\nEP 2 592 085 B1 2016","journal-title":"Thiazolo[3,2-a][1,3]diazepine derivatives\nand pharmaceutical compositions containing the same as novel anticonvulsant\nagents and method for their preparation Europ Pat\nEP 2 592 085 B1"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1016\/j.ejmech.2011.09.021","volume":"46","author":"El-Subbagh H.I.","year":"2011","unstructured":"El-Subbagh H.I.; Hassan G.S.; El-Azab A.S.; Abdel-Aziz A.A-M.; Kadi A.A.; Al-Obaid A.M.; Al-Shabanah O.A.; Sayed-Ahmed M.M.; Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues. Eur J Med Chem 2011,46(11),5567-5572","journal-title":"Eur J Med Chem"},{"key":"ref=29","author":"Hassan G.S.","year":"2013","unstructured":"Hassan G.S.; El-Subbagh H.I.; Al-Omar M.A.; El-Taher K.E.H.; Al-Rashood K.A.; Al-Obaid A.M.; Al-Azab A.S.; Abdelaziz A.A-M.; Al-Omary F.A.; Hefnawy M.M.;  6,7-Dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical\ncompositions containing the same as hypnotic or anesthetic\nagent and method for their preparation Europ Pat EP 2 514 753\nB1, 2013","journal-title":"6,7-Dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical\ncompositions containing the same as hypnotic or anesthetic\nagent and method for their preparation Europ Pat EP 2 514 753\nB1,"},{"key":"ref=30","author":"Hassan G.S.","year":"2014","unstructured":"Hassan G.S.; El-Subbagh H.I.; Al-Omar M.A.; El-Taher K.E.H.; Al-Rashood K.A.; Al-Obaid A.M.; Al-Azab A.S.; Abdelaziz A.A-M.; Al-Omary F.A.; Hefnawy M.M.;  6,7-Dihydro-\n[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical\ncompositions containing the same as hypnotic or anesthetic\nagent and method for their preparation United States patent US\n8,741,893 B2, 2014","journal-title":"6,7-Dihydro-\n[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical\ncompositions containing the same as hypnotic or anesthetic\nagent and method for their preparation United States patent US\n8,741,893 B2,"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0014-2999(82)90359-4","volume":"81","author":"Fredholm B-B.","year":"1982","unstructured":"Fredholm B-B.; Persson C.G.; Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol 1982,81(4),673-676","journal-title":"Eur J Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0165-6147(83)90365-6","volume":"4","author":"Janssen P.A.J.","year":"1983","unstructured":"Janssen P.A.J.; 5-HT2 Receptor blockade to study serotonin-induced pathology. Trends Pharmacol Sci 1983,4,198-206","journal-title":"Trends Pharmacol Sci"},{"key":"ref=33","first-page":"265","volume":"9","author":"Macdonald R.L.","year":"1992","unstructured":"Macdonald R.L.; Twyman R.E.G.; Ryan-Jastrow T.; Angelotti T.P.;  Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylationEpilepsy Res Suppl, 1992,9,265-277","journal-title":"Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylationEpilepsy Res Suppl,"},{"key":"ref=34","first-page":"73","volume":"38","author":"Haefely W.","year":"1983","unstructured":"Haefely W.;  Antagonists of benzodiazepines: Functional aspects Adv Biochem Psychopharmacol, 1983,38,73-93","journal-title":"Antagonists of benzodiazepines: Functional aspects Adv Biochem Psychopharmacol,"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00310505","volume":"88","author":"File S.E.","year":"1986","unstructured":"File S.E.; Pellow S.; Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berl) 1986,88(1),1-11","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2165\/00003495-198835040-00004","volume":"35","author":"Brogd\u00e9n R.N.","year":"1988","unstructured":"Brogd\u00e9n R.N.; Goa K.L.; Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs 1988,35(4),448-467","journal-title":"Drugs"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejmech.2016.08.038","volume":"124","author":"El-Subbagh H.I.","year":"2016","unstructured":"El-Subbagh H.I.; Hassan G.S.; El-Taher K.E.H.; El-Messery S.M.; Al-Azab A.S.; Abdelaziz A.A-M.; Hefnawy M.M.; Synthesis, biological evaluation and molecular modeling study of thiadiazolo[3,2-a][1,3]diazepine analogues of HIE-124 as a new class of short acting hypnotics. Eur J Med Chem 2016,124,237-247","journal-title":"Eur J Med Chem"},{"key":"ref=38","author":"Al-Azab A.S.","year":"2013","unstructured":"Al-Azab A.S.; El-Subbagh H.I.; Al-Rashood K.A.; El-Taher K.E.H.; Al-Omar M.A.; Hassan G.S.; Al-Omary F.A.; Abdelaziz A.A-M.; Hefnawy M.A.;  6,7-dihydro-[1,3,4]thiadiazolo-[3,2-\na][1,3]diazepin derivative and pharmaceutical composition containing\nthe same as neuromuscular blocker or skeletal muscle relaxant,\nand method for the preparation Europ Pat EP 2 514 754 B1, 2013","journal-title":"6,7-dihydro-[1,3,4]thiadiazolo-[3,2-\na][1,3]diazepin derivative and pharmaceutical composition containing\nthe same as neuromuscular blocker or skeletal muscle relaxant,\nand method for the preparation Europ Pat EP 2 514 754 B1,"},{"key":"ref=39","author":"Al-Azab A.S.","year":"2014","unstructured":"Al-Azab A.S.; El-Subbagh H.I.; Al-Rashood K.A.; El-Taher K.E.H.; Al-Omar M.A.; Hassan G.S.; Al-Omary F.A.; Abdelaziz A.A-M.; Hefnawy M.A.;  6,7-dihydro-[1,3,4]thiadiazolo-[3,2-\na][1,3]diazepin derivative and pharmaceutical composition containing\nthe same as neuromuscular blocker or skeletal muscle relaxant,\nand method for the preparation United States patent US\n8,846,665 B2, 2014","journal-title":"6,7-dihydro-[1,3,4]thiadiazolo-[3,2-\na][1,3]diazepin derivative and pharmaceutical composition containing\nthe same as neuromuscular blocker or skeletal muscle relaxant,\nand method for the preparation United States patent US\n8,846,665 B2,"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1476-5381.1993.tb12867.x","volume":"108","author":"Henning R.H.","year":"1993","unstructured":"Henning R.H.; Nelemans A.; Houwertjes M.; Agoston S.; Reversal by suramin of neuromuscular block produced by pancuronium in the anaesthetized rat. Br J Pharmacol 1993,108(3),717-720","journal-title":"Br J Pharmacol"},{"key":"ref=41","first-page":"99","volume":"111","author":"Thesleff S.","year":"1954","unstructured":"Thesleff S.; Unna K.R.;  Differences in mode of neuromuscular\nblockade in a series of symmetric bis-quaternary ammonium salts\nJ Pharmacol Exp Ther, 1954,111(1),99-113","journal-title":"Differences in mode of neuromuscular\nblockade in a series of symmetric bis-quaternary ammonium salts\nJ Pharmacol Exp Ther,"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.2042-7158.1949.tb12517.x","volume":"1","author":"Buttle G.A.H.","year":"1949","unstructured":"Buttle G.A.H.; Zamis E.J.; The action of decamethonium in birds. J Pharm Pharmacol 1949,1,991-992","journal-title":"J Pharm Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"35793","DOI":"10.1074\/jbc.M113.508333","volume":"288","author":"Mowrey D.D.","year":"2013","unstructured":"Mowrey D.D.; Liu Q.; Bondarenko V.; Chen Q.; Seyoum E.; Xu Y.; Wu J.; Tang P.; Insights into distinct modulation of \u03b17 and \u03b17\u03b22 nicotinic acetylcholine receptors by the volatile anesthetic isoflurane. J Biol Chem 2013,288(50),35793-35800","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejmech.2016.09.096","volume":"126","author":"El-Subbagh H.I.","year":"2017","unstructured":"El-Subbagh H.I.; El-Azab A.S.; Hassan G.S.; El-Messery S.M.; Abdel-Aziz A.A-M.; El-Taher K.E.H.; Thiadiazolodiazepine analogues as a new class of neuromuscular blocking agents: Synthesis, biological evaluation and molecular modeling study. Eur J Med Chem 2017,126,15-23","journal-title":"Eur J Med Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521999201230195733","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189653\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521999201230195733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T07:57:58Z","timestamp":1660463878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189653\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521999201230195733","relation":{},"ISSN":["1389-5575"],"issn-type":[{"type":"print","value":"1389-5575"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}